Neoadjuvant chemotherapy versus upfront debulking surgery in advanced tubo-ovarian cancer

被引：10
|
作者：
Fagotti, Anna [1 ,2 ]
Scambia, Giovanni [1 ,2 ]
机构：
[1] Fdn Policlin Univ Agostino Gemelli, IRCCS, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Rome, Italy
来源：
LANCET ONCOLOGY | 2018年 / 19卷 / 12期
关键词：
OVARIAN-CANCER;
D O I：
10.1016/S1470-2045(18)30625-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1558 / 1560
页数：3
相关论文
共 50 条
  • [21] Primary debulking surgery versus neoadjuvant chemotherapy in advanced stage ovarian cancer;reality in a single center
    Akilli, Huseyin
    Gunakan, Emre
    Aysun, Dide
    Tekelioglu, Tugba
    Kuscu, Esra
    Haberal, Ali
    Ayhan, Ali
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A167 - A167
  • [22] Clinical Outcome of Iranian Patients with Advanced Ovarian Cancer with Neoadjuvant Chemotherapy versus Primary Debulking Surgery
    Ghaemmaghami, Fatemeh
    Karimi-Zarchi, Mojgan
    Modares-Gilani, Mitra
    Mousavi, Azamsadat
    Behtash, Nadereh
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2008, 9 (04) : 719 - 724
  • [23] The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer
    Rosen, Barry
    Laframboise, Stephane
    Ferguson, Sarah
    Dodge, Jason
    Bernardini, Marcus
    Murphy, Joan
    Segev, Yakir
    Sun, Ping
    Narod, Steven A.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (03) : 462 - 467
  • [24] Laparoscopic interval debulking surgery for advanced ovarian cancer after neoadjuvant chemotherapy
    Jorgensen, K.
    Melamed, A.
    Bradford, L.
    Wang, V.
    Chang, H.
    Rauh-Hain, J. A.
    Schorge, J.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 49 - 50
  • [25] Debulking Surgery in Advanced Epithelial Ovarian Cancer: Interval or at the End of Neoadjuvant Chemotherapy?
    F. Cantu-de Leon, D.
    Gallardo-Alvarado, L.
    Salcedo-Hernandez, R.
    Ramirez, R.
    Perez-Montiel, D.
    Onate-Ocana, L.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S86 - S86
  • [26] Laparoscopic interval debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer
    Nitecki, R.
    Melamed, A.
    Boruta, D. M., II
    del Carmen, M. G.
    Clark, R. M.
    Growdon, W. B.
    Goodman, A.
    Schorge, J. O.
    Rauh-Hain, J. A.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 125 - 125
  • [27] Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer
    Rauh-Hain, J. Alejandro
    Rodriguez, Noah
    Growdon, Whitfield B.
    Goodman, A. K.
    Boruta, David M., II
    Horowitz, Neil S.
    del Carmen, Marcela G.
    Schorge, John O.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (03) : 959 - 965
  • [28] Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer
    Rauh-Hain, I.
    Growdon, W.
    Rodriguez, N.
    Goodman, A.
    Boruta, D.
    Horowitz, N.
    Del Carmen, M.
    Schorge, J.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S12 - S13
  • [29] Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer
    J. Alejandro Rauh-Hain
    Noah Rodriguez
    Whitfield B. Growdon
    A. K. Goodman
    David M. Boruta
    Neil S. Horowitz
    Marcela G. del Carmen
    John O. Schorge
    Annals of Surgical Oncology, 2012, 19 : 959 - 965
  • [30] PRIMARY DEBULKING SURGERY OR NEOADJUVANT CHEMOTHERAPY FOLLOWED BY INTERVAL DEBULKING SURGERY FOR PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER?
    Mansouri, H.
    Zemni, I.
    Ben Safta, I.
    Achouri, L.
    Ben Hassouna, J.
    Hechiche, M.
    Chargui, R.
    Rahal, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A120 - A120
12345